TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis.
Zonneveld-Huijssoon E, van Wijk F, Roord S, Delemarre E, Meerding J, de Jager W, Klein M, Raz E, Albani S, Kuis W, Boes M, Prakken BJ.
Zonneveld-Huijssoon E, et al. Among authors: albani s.
Ann Rheum Dis. 2012 Oct;71(10):1706-15. doi: 10.1136/annrheumdis-2011-201131. Epub 2012 May 5.
Ann Rheum Dis. 2012.
PMID: 22562976